𝐇𝐞𝐚𝐥𝐭𝐡 𝟐𝟎𝟑𝟓 𝐒𝐮𝐦𝐦𝐢𝐭: Investor Dr. D. Martin Alexander Gershon, MD, JD, MPH describes how technology has played an increasingly central role in his investment focus. He describes how technology is changing healthcare at all levels, including hospitals, drug developers, the and patient experience. Plus, he shares a few portfolio company investments as examples. Full video: https://lnkd.in/gJ7QGfdc BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
About us
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
- Website
-
https://www.biotechtv.com
External link for BiotechTV
- Industry
- Internet News
- Company size
- 2-10 employees
- Headquarters
- Seaport, Boston
- Type
- Privately Held
- Founded
- 2023
- Specialties
- Biotech and News
Locations
-
Primary
Seaport, Boston, US
Employees at BiotechTV
Updates
-
𝐇𝐞𝐚𝐥𝐭𝐡 𝟐𝟎𝟑𝟓 𝐒𝐮𝐦𝐦𝐢𝐭: Kristen Dahlgren, founder and CEO of the Cancer Vaccine Coalition, discusses vaccines for breast cancer and beyond. She describes what motivated her to start the Cancer Vaccine Coalition after a career as a news reporter, promising breast cancer vaccines the coalition aims to support, and vaccines for other cancers. Full video: https://lnkd.in/guu_3VBX BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
𝐇𝐞𝐚𝐥𝐭𝐡 𝟐𝟎𝟑𝟓 𝐒𝐮𝐦𝐦𝐢𝐭: Roivant Sciences' CEO Matthew Gline on why he believes this is a good time to be hunting for assets on the shelves of big pharma, and upcoming catalysts He describes why this may be a good time to asset hunt, but also why Roivant has been conservative with its cash. Plus upcoming catalysts in FcRN, TYK2xJAK1, GM-CSF, and more. Full video: https://lnkd.in/giUgj3uR BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
𝐇𝐞𝐚𝐥𝐭𝐡 𝟐𝟎𝟑𝟓 𝐒𝐮𝐦𝐦𝐢𝐭: Luke Timmerman recaps last week's Timmerman Traverse charity climb in the Cascades, and more. He recaps this fourth Timmerman Traverse event that raised $1 million for Life Science Cares, and talks about other upcoming climbs. Plus, his thoughts on what is exciting in biotech today. Full video: https://lnkd.in/gDj4adMR BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
𝐇𝐞𝐚𝐥𝐭𝐡 𝟐𝟎𝟑𝟓 𝐒𝐮𝐦𝐦𝐢𝐭: Kicking off the Health 2035 Summit in New York with co-hosts Katherine Andersen of HSBC Innovation Banking and Hamid Ghanadan of LINUS. Katherine and Hamid describe today's event that is meant for leaders from across healthcare to discuss and think about where the industry is headed over the long term. #sponsored
-
𝐄𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧: BioversityMA, a nonprofit launched by MassBio, is teaching underrepresented students the basics of lab work and professional skills to prepare them for jobs in life sciences. Executive Director Zach Stanley describes the program and how to get involved, and recent college graduate Denise Mitchell gives a student's perspective of what Bioversity teaches and offers. Link: https://lnkd.in/gPSDnWH7 BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Checking in with Artiva Biotherapeutics' CEO Fred Aslan after the NK cell focused company's $167 million IPO. He describes what the funds will enable Artiva to do in the clinic, and why he believes the company's non-modified NK cell approach is the best platform for using a cell therapy for autoimmune conditions. Full video: https://lnkd.in/gFpZ5DNX BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Praxis Precision Medicines, Inc.'s CEO Marcio Souza discusses the company's CNS focus and key data that is scheduled for this year He describes Praxis' small molecule and antisense oligonucleotide platforms, and previews key trials that will have near term data events. Full video: https://lnkd.in/ggYKzwrY BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Illumina held a ‘Strategy Update’ event today, the first since Jacob Thaysen became CEO last September. He shares highlights and his vision for the company with BiotechTV. He covers Illumina’s business today, including the NovaSeq X platform, multiomics, clinical and pharma industry applications, and his case for getting Illumina back to financial growth. Full video: https://lnkd.in/gnc_c99Z BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: Avidity Biosciences, Inc.'s CEO Sarah Boyce discusses the company's Exon 44 skipping data in DMD that showed a 25% increase in dystrophin production. She describes how this PMO based antibody oligonucleotide conjugate works and why she believes the result validates her belief that Avidity has the strongest delivery in the field. Full video: https://lnkd.in/gqsvVzE4 BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent